115 related articles for article (PubMed ID: 11167675)
1. Immunophenotyping of Sézary cells.
Russell-Jones R
Br J Dermatol; 2001 Jan; 144(1):2-3. PubMed ID: 11167675
[No Abstract] [Full Text] [Related]
2. Expression of CD164 on Malignant T cells in Sézary Syndrome.
Guenova E; Ignatova D; Chang YT; Contassot E; Mehra T; Saulite I; Navarini AA; Mitev V; Dummer R; Kazakov DV; French LE; Hoetzenecker W; Cozzio A
Acta Derm Venereol; 2016 May; 96(4):464-7. PubMed ID: 26524186
[TBL] [Abstract][Full Text] [Related]
3. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
[TBL] [Abstract][Full Text] [Related]
4. The Sézary syndrome: hematologic criteria.
Vonderheid EC; Bernengo MG
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1367-89, viii. PubMed ID: 14710890
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis of cutaneous T-cell lymphomas.
Bagot M; Boumsell L; Bensussan A
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1313-7, vii. PubMed ID: 14710886
[TBL] [Abstract][Full Text] [Related]
6. From single-cell signature to prognostic factors: the case of Sézary syndrome.
Scala E; Narducci MG; Russo G
Expert Rev Clin Immunol; 2012 Nov; 8(8):699-701. PubMed ID: 23167680
[No Abstract] [Full Text] [Related]
7. [KIR3DL2: a new step for the management of patients with Sezary syndrome].
Ortonne N; Bagot M; Bensussan A
Med Sci (Paris); 2006; 22(8-9):691-3. PubMed ID: 16962036
[No Abstract] [Full Text] [Related]
8. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.
Poszepczynska-Guigné E; Schiavon V; D'Incan M; Echchakir H; Musette P; Ortonne N; Boumsell L; Moretta A; Bensussan A; Bagot M
J Invest Dermatol; 2004 Mar; 122(3):820-3. PubMed ID: 15086570
[TBL] [Abstract][Full Text] [Related]
9. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
Meissner K; Löning T; Rehpenning W
Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
[TBL] [Abstract][Full Text] [Related]
10. Rapid progression of immune dysregulation in an HIV-infected patient with Sézary syndrome.
Dadoo AS; Steenkamp I
Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710903
[TBL] [Abstract][Full Text] [Related]
11. SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells.
Huet D; Bagot M; Loyaux D; Capdevielle J; Conraux L; Ferrara P; Bensussan A; Marie-Cardine A
J Immunol; 2006 Jan; 176(1):652-9. PubMed ID: 16365461
[TBL] [Abstract][Full Text] [Related]
12. [Surface membrane markers (clusters of differentiation) used in dermatopathology (1): The lymphocyte markers].
Ingen-Housz-Oro S; Ortonne N
Ann Dermatol Venereol; 2015 Oct; 142(10):598-606. PubMed ID: 26169897
[No Abstract] [Full Text] [Related]
13. Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients.
Bensussan A; Janela B; Thonnart N; Bagot M; Musette P; Ginhoux F; Marie-Cardine A
J Invest Dermatol; 2019 Mar; 139(3):725-728. PubMed ID: 30798854
[No Abstract] [Full Text] [Related]
14. A Long-Term Study of Persistent Sézary Syndrome: Evidence for Antigen Shift by Multiparameter Flow Cytometry and Its Significance in Overall Survival.
Hoffmann JC; Atwater SK; Hong E; Kumar J; Khodadoust M; Kim Y; Ohgami RS
Am J Dermatopathol; 2020 Jun; 42(6):389-396. PubMed ID: 32433315
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Sézary syndrome in a patient with generalized pruritus based on early molecular study and flow cytometry.
Bowen GM; Stevens SR; Dubin HV; Siddiqui J; Cooper KD
J Am Acad Dermatol; 1995 Oct; 33(4):678-80. PubMed ID: 7673506
[No Abstract] [Full Text] [Related]
16. Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
Sokołowska-Wojdyło M; Barańska-Rybak W; Cegielska A; Trzeciak M; Lugowska-Umer H; Gniadecki R
Acta Derm Venereol; 2011 Sep; 91(5):574-7. PubMed ID: 21681350
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and immunological characteristics of erythrodermal lymphomas of the skin].
Shaposhnikov OK; Rodionov AN; Karachunova TN
Vestn Dermatol Venerol; 1985 Jan; (1):4-9. PubMed ID: 3156460
[No Abstract] [Full Text] [Related]
18. Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up.
Novelli M; Fava P; Sarda C; Ponti R; Osella-Abate S; Savoia P; Bergallo M; Lisa F; Fierro MT; Quaglino P
Am J Clin Pathol; 2015 Jan; 143(1):57-69. PubMed ID: 25511143
[TBL] [Abstract][Full Text] [Related]
19. Management of cutaneous T-cell lymphoma: The future is here.
Wood GS
J Am Acad Dermatol; 2001 Aug; 45(2):317. PubMed ID: 11464201
[No Abstract] [Full Text] [Related]
20. [Cutaneous neutrophils infiltrates. Case 7. Lymphomatoid papulosis].
Vergier B
Ann Pathol; 2011 Jun; 31(3):198-202. PubMed ID: 21737002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
